# TAP Block With Lidocaine and Ropivacaine 0.2% (0.4 ml/kg/Side) for Pain and Opioid Reduction After Hysterectomy

> **NCT07139691** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Matild Keresztes** · enrollment: 82 (estimated)

## Conditions studied

- Postoperative Pain Following Hysterectomy

## Interventions

- **PROCEDURE:** Pre-incisional Transversus Abdominis Plane (TAP) block performed under ultrasound guidance. The block will be administered bilaterally using a mixture of lidocaine and ropivacaine 0.2%
- **DRUG:** Participants in this arm will receive standard analgesia for postoperative pain management following elective hysterectomy

## Key facts

- **NCT ID:** NCT07139691
- **Lead sponsor:** Matild Keresztes
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-12
- **Primary completion:** 2026-07-01
- **Final completion:** 2026-12-31
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07139691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07139691, "TAP Block With Lidocaine and Ropivacaine 0.2% (0.4 ml/kg/Side) for Pain and Opioid Reduction After Hysterectomy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07139691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*